The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Surmontil 25mg film-coated Tablets



Neuraxpharm Ireland LimitedPA23229/009/002

Main Information

Trade NameSurmontil 25mg film-coated Tablets
Active SubstancesTrimipramine
Dosage FormFilm-coated tablet
Licence HolderNeuraxpharm Ireland Limited
Licence NumberPA23229/009/002

Group Information

ATC CodeN06AA Non-selective monoamine reuptake inhibitors
N06AA06 trimipramine

Status

License statusAuthorised
Licence Issued01/04/1978
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back